Deficient Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Death Receptor Transport to the Cell Surface in Human Colon Cancer Cells Selected for Resistance to TRAIL-induced Apoptosis
Open Access
- 20 August 2004
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 279 (34), 35829-35839
- https://doi.org/10.1074/jbc.m405538200
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAILOnline Journal of Public Health Informatics, 1998
- TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signallingFEBS Letters, 1998
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor geneNature Genetics, 1997
- TRAIL-R2: a novel apoptosis-mediating receptor for TRAILThe EMBO Journal, 1997
- Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy ReceptorsScience, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyOnline Journal of Public Health Informatics, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995